Hydroxychloroquine is looming “fine and well” as one of the main actors of the soap opera dark this spring’s unusual.
After the New England Journal of Medicine expressed yesterday its reserves on the study of the Pr Mehra says through the voice of its editor-in-chief Eric ,
Warning (expression of a call to prudence) : Hydroxychloroquine or chloroquine with or without a macrolide for the treatment of COVID-19 : of important scientific questions have been raised about the data reported in the article by Mandeep Mehra and published in The Lancet on 22 may 2020. Mr Mehra had also been interviewed by our care on the same day, resulting in immediately our doubts :
Although an independent audit of the origin and validity of the data has been ordered by authors not affiliated with Surgisphere, and that it is ongoing, with results expected very soon, The Lancet published an expression of concern to alert readers to the fact that serious scientific questions have been brought to their attention. The notice will be updated as soon as new information becomes available.
Moreover, we had been the only French press to raise doubts from the beginning and try to understand how such an institution such as The Lancet, was able to publish such a paper.
Our request to the Director of the Publication on the checks and validations carried out prior to the publication in The Lancet has remained unanswered to this day.
Important questions will no doubt arise as to the validity of these studies “big data”, which can be extremely useful for the identification of weak signals that are invisible to the naked eye. This looks more and more to a manipulation of the opinion, leading even the minister of Health has to enter the HCSP.
Also read :
LancetGate : Surgisphere the company that provided the data for the study is it serious ?
Author(s): FranceSoir
